JP2023514128A5 - - Google Patents

Info

Publication number
JP2023514128A5
JP2023514128A5 JP2022547164A JP2022547164A JP2023514128A5 JP 2023514128 A5 JP2023514128 A5 JP 2023514128A5 JP 2022547164 A JP2022547164 A JP 2022547164A JP 2022547164 A JP2022547164 A JP 2022547164A JP 2023514128 A5 JP2023514128 A5 JP 2023514128A5
Authority
JP
Japan
Prior art keywords
amino acid
ligand
seq
acid sequence
7rαγc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022547164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514128A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/016361 external-priority patent/WO2021158623A1/en
Publication of JP2023514128A publication Critical patent/JP2023514128A/ja
Publication of JP2023514128A5 publication Critical patent/JP2023514128A5/ja
Pending legal-status Critical Current

Links

JP2022547164A 2020-02-03 2021-02-03 IL-7Rαγc結合化合物 Pending JP2023514128A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062969432P 2020-02-03 2020-02-03
US62/969,432 2020-02-03
US202063041158P 2020-06-19 2020-06-19
US63/041,158 2020-06-19
PCT/US2021/016361 WO2021158623A1 (en) 2020-02-03 2021-02-03 IL-7Rαγc BINDING COMPOUNDS

Publications (2)

Publication Number Publication Date
JP2023514128A JP2023514128A (ja) 2023-04-05
JP2023514128A5 true JP2023514128A5 (cg-RX-API-DMAC7.html) 2024-02-14

Family

ID=77200524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022547164A Pending JP2023514128A (ja) 2020-02-03 2021-02-03 IL-7Rαγc結合化合物

Country Status (12)

Country Link
US (2) US11746139B2 (cg-RX-API-DMAC7.html)
EP (1) EP4100427A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023514128A (cg-RX-API-DMAC7.html)
KR (1) KR20220139918A (cg-RX-API-DMAC7.html)
CN (1) CN115315435A (cg-RX-API-DMAC7.html)
AU (2) AU2021217353A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022015002A2 (cg-RX-API-DMAC7.html)
CA (1) CA3166816A1 (cg-RX-API-DMAC7.html)
IL (1) IL295304A (cg-RX-API-DMAC7.html)
MX (1) MX2022009390A (cg-RX-API-DMAC7.html)
TW (2) TWI812918B (cg-RX-API-DMAC7.html)
WO (1) WO2021158623A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210055694A (ko) 2018-08-06 2021-05-17 메디카인 인코포레이티드 Il-2 수용체 결합 화합물
CA3160466A1 (en) 2019-11-05 2021-05-14 Medikine, Inc. Dual il-2r and il-7r binding compounds
MX2022005411A (es) 2019-11-05 2022-08-10 Medikine Inc COMPUESTOS DE UNIÓN A IL-2RßYC.
US11746139B2 (en) * 2020-02-03 2023-09-05 Medikine, Inc. IL-7Rαγc binding compounds
AU2021217959A1 (en) * 2020-02-03 2022-08-18 Medikine, Inc. IL-7Rα binding compounds
EP4240394A4 (en) * 2020-11-04 2024-10-23 Medikine, Inc. IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF
US20250082777A1 (en) 2022-01-10 2025-03-13 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
WO2023193015A1 (en) 2022-04-01 2023-10-05 Sana Biotechnology, Inc. Cytokine receptor agonist and viral vector combination therapies
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins
US20240101959A1 (en) 2022-09-06 2024-03-28 Medikine, Inc. Use of il-2r-beta-gamma agonist peptides in cell manufacturing
US20240100159A1 (en) 2022-09-06 2024-03-28 Medikine, Inc. Use of il-7r-alpha-gamma agonist peptides in cell manufacturing

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635597A (en) 1994-05-27 1997-06-03 Affymax Technologies, N.V. Peptides that bind IL-2 receptors
EP1454138B1 (en) 2001-12-04 2012-01-18 Merck Patent GmbH Immunocytokines with modulated selectivity
US20050054054A1 (en) * 2002-11-12 2005-03-10 Foss Francine M. Interleukin-7 molecules with altered biological properties
KR101163424B1 (ko) 2003-12-30 2012-07-13 메르크 파텐트 게엠베하 Il-7 융합 단백질
CN101072793B (zh) 2004-12-09 2012-06-20 默克专利有限公司 具有降低的免疫原性的il-7变体
EP1828231A2 (en) 2004-12-22 2007-09-05 Novartis Vaccines and Diagnostics, Inc. Group b streptococcus
US20120210458A9 (en) 2009-02-27 2012-08-16 Yongwei Cao Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Thereof
ES2866674T3 (es) 2010-11-12 2021-10-19 Nektar Therapeutics Conjugados de una fracción de IL-2 y un polímero
EP2649094B1 (en) * 2010-12-10 2016-04-27 University of Central Florida Research Foundation, Inc. Methods and compositions comprising il-7 receptor ligands
CA2824515C (en) 2011-01-18 2022-09-13 Bioniz, Llc Compositions and methods for modulating gamma-c-cytokine activity
JP6592505B2 (ja) 2014-04-24 2019-10-16 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー インターロイキン−2のスーパーアンタゴニスト、パーシャルアゴニスト及びアンタゴニスト
KR102493543B1 (ko) 2014-07-21 2023-01-30 데리니아, 인크. 자가면역 질환의 치료를 위한 조절 t 세포를 선택적으로 활성화시키는 분자
JP6640834B2 (ja) 2014-08-11 2020-02-05 デリニア, インコーポレイテッド 自己免疫疾患の処置のために調節性t細胞を選択的に活性化させる改変il−2変異体
PT3328894T (pt) * 2015-08-06 2019-02-13 Agency Science Tech & Res Anticorpos de cadeia comum gama/il2rbeta
KR102908806B1 (ko) 2015-10-22 2026-01-07 주노 테라퓨틱스 게엠베하 세포의 배양 방법 및 이를 위한 키트와 장치
US20170204154A1 (en) 2016-01-20 2017-07-20 Delinia, Inc. Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases
US11053293B2 (en) 2016-02-05 2021-07-06 Washington University Compositions and methods for targeted cytokine delivery
EP3538548A4 (en) 2016-11-08 2020-08-19 Delinia, Inc. IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
CN110392695B (zh) * 2016-12-09 2021-02-02 Ose免疫疗法 针对cd127的抗体和多肽
CN110177564A (zh) 2016-12-13 2019-08-27 德里尼亚公司 多价的调节t细胞调节剂
KR20210055694A (ko) 2018-08-06 2021-05-17 메디카인 인코포레이티드 Il-2 수용체 결합 화합물
WO2020247388A2 (en) 2019-06-03 2020-12-10 Medikine, Inc. Il-2alpha receptor subunit binding compounds
MX2022005411A (es) 2019-11-05 2022-08-10 Medikine Inc COMPUESTOS DE UNIÓN A IL-2RßYC.
US20220119492A1 (en) 2019-11-05 2022-04-21 Medikine, Inc. Il-2r-beta-gamma binding compounds and uses thereof
CA3160466A1 (en) 2019-11-05 2021-05-14 Medikine, Inc. Dual il-2r and il-7r binding compounds
TW202136287A (zh) 2019-12-17 2021-10-01 法商Ose免疫治療公司 包含il-7變體之雙官能分子
AU2021217959A1 (en) 2020-02-03 2022-08-18 Medikine, Inc. IL-7Rα binding compounds
US11746139B2 (en) 2020-02-03 2023-09-05 Medikine, Inc. IL-7Rαγc binding compounds
EP4240394A4 (en) 2020-11-04 2024-10-23 Medikine, Inc. IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins

Similar Documents

Publication Publication Date Title
JP6192891B2 (ja) 改善されたフィブロネクチンベースの結合分子およびそれらの使用
JP2022553826A5 (cg-RX-API-DMAC7.html)
JP2019533449A5 (cg-RX-API-DMAC7.html)
JP2015509097A5 (cg-RX-API-DMAC7.html)
JP2016527314A5 (cg-RX-API-DMAC7.html)
JP2023504914A5 (cg-RX-API-DMAC7.html)
JP2019503990A5 (cg-RX-API-DMAC7.html)
JP2018171063A5 (cg-RX-API-DMAC7.html)
JP2019514361A5 (cg-RX-API-DMAC7.html)
JP2024063213A5 (cg-RX-API-DMAC7.html)
JP2016000731A5 (cg-RX-API-DMAC7.html)
JP2022526595A5 (cg-RX-API-DMAC7.html)
RU2007126553A (ru) Упорядоченные ряды антигенов ил-15 и их применение
JP2015212284A5 (cg-RX-API-DMAC7.html)
JP2018510637A5 (cg-RX-API-DMAC7.html)
JP2017500018A5 (cg-RX-API-DMAC7.html)
JP2016524592A (ja) Icoslへの治療上の標的特異的vnarドメインの単離
JP2020524661A5 (cg-RX-API-DMAC7.html)
CN114736291B (zh) 特异性结合发热伴血小板减少综合征病毒的囊膜蛋白Gn的人源单克隆抗体及其用途
JP2017504321A5 (cg-RX-API-DMAC7.html)
CN111542546A (zh) 抗lag-3 抗体及其用途
JP2017534296A5 (cg-RX-API-DMAC7.html)
JP2023552462A5 (cg-RX-API-DMAC7.html)
JP2021512159A5 (cg-RX-API-DMAC7.html)
JP2008521426A5 (cg-RX-API-DMAC7.html)